Company Overview of Biscayne Pharmaceuticals, Inc.
Biscayne Pharmaceuticals, Inc. operates as a biopharmaceutical company that develops therapies based on growth hormone-releasing hormone (GHRH) analogs. The compounds include GHRH antagonists in development for the treatment of cancer, including castrate-resistant prostate cancer, and GHRH agonists for the repair of cardiac damage in heart disease patients. The company was incorporated in 2012 and is headquartered in Miami, Florida.
4770 Biscayne Boulevard
Miami, FL 33137
Founded in 2012
Key Executives for Biscayne Pharmaceuticals, Inc.
Biscayne Pharmaceuticals, Inc. Key Developments
Similar Private Companies By Industry
|Icon Genetics, Inc.||United States|
|Origen Therapeutics, Inc.||United States|
|Pathogen Removal and Diagnostic Technologies, Inc.||United States|
|Pointilliste, Inc||United States|
|GlycoMark, Inc.||United States|
Recent Private Companies Transactions
April 11, 2014
To contact Biscayne Pharmaceuticals, Inc., please visit biscaynepharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.